Earnings Per Share Data - Additional Information (Detail) - shares	3 Months Ended
Dec. 31, 2020	Dec. 31, 2019
Exercisable stock options, included in the diluted earnings per share calculation	252,000	272,000
Effect of dilutive stock options	123,000	134,000
Inclusive Of Diluted Earning [Member]
Anti-dilutive shares	0	0

Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 23
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256

Name:	us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration